Industry / Bosnia-Herzegovina
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Bosnalijek Looking For Closer Ties With Libya
March 2008 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Bosnalijek, the largest drugmaker in Bosnia and Herzegovina, is planning to increase its partnership with Libya's government. It is also looking to increase its co-operation with Libyan pharmaceutical firm Al Rabta, and may even consider a takeover bid.